Stem cell injection for hepatitis B cirrhosis
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests an injection of stem cells from donated umbilical cords to see if it can help people with advanced liver scarring from hepatitis B. You may be able to join if standard treatments haven’t helped enough and you aren’t able to get a liver transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with advanced liver scarring (cirrhosis) caused by hepatitis B that has led to complications like fluid buildup or bleeding.
- You’ve had at least 3 months of standard medical treatments (including antivirals and supportive care) without enough improvement.
- Your hepatitis B virus level is very low (under 2,000 IU per mL).
- You are not a candidate for a liver transplant or don’t have a donor available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether stem cells from umbilical cord blood can safely help people with advanced liver scarring (cirrhosis) caused by hepatitis B. It may offer a new option for those who haven't improved with usual treatments.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
This Phase 1 study tests a stem cell product to see if it is safe and how it affects people with worsening hepatitis B-related cirrhosis. It may help researchers understand whether the treatment could improve liver function in this stage of illness.
This trial tests whether a stem cell infusion made from umbilical cord tissue can help people with severe liver failure caused by hepatitis B. The stem cells may reduce liver damage and improve recovery.
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
This study tests a new treatment using stem cells for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. The goal is to see if it is safe and if it can help improve liver function.
Hear when a new Decompensated Hepatitis B Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.